BLFS logo

BLFS

BioLife Solutions Inc.

$25.05
+$0.13(+0.52%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$1.23B
Volume
354.49K
52W Range
$19.10 - $29.55
Target Price
$31.30
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$6.4M$8.2M$11.0M$19.7M$27.4M$48.1M$119.2M$161.8M$75.9M$82.3M
Total Revenue
$6.4M$8.2M$11.0M$19.7M$27.4M$48.1M$119.2M$161.8M$75.9M$82.3M
COST OF GOODS SOLD
Cost of Revenue
$-2.6M$-3.4M$-4.3M$-6.2M$8.4M$20.6M$82.1M$107.9M$96.5M--
GROSS PROFIT
Gross Profit
$3.8M$4.8M$6.7M$-6.2M$19.0M$27.4M$37.0M$53.8M$45.9M$82.3M
OPERATING EXPENSES
Operating Expenses
$-8.8M$-9.6M$-7.8M$9.9M$18.8M$31.4M$69.3M$93.7M$71.6M$60.8M
Research & Development
$1.4M$2.0M$1.2M$1.3M$3.2M$6.7M$11.8M$14.8M$12.1M$7.9M
Research Expense
$1.4M$2.0M$1.2M$1.3M$3.2M$6.7M$11.8M$14.8M$12.1M$7.9M
Selling, General & Administrative
$7.5M$7.6M$6.6M$8.6M$13.6M$21.0M$47.7M$69.2M$56.0M$50.2M
Selling & Marketing Expenses
$2.6M$3.0M$2.1M$2.6M$4.7M$6.4M$14.0M$21.6M$12.7M$9.6M
General & Administrative Expenses
$4.9M$4.6M$4.5M$6.0M$8.9M$14.6M$33.7M$47.7M$43.3M$40.5M
Promotion & Advertising
$-69.1K$-74.9K$-39.0K$-30.0K$43.0K$167.0K$552.0K----$900.0K
Salaries & Wages
$-511.5K$-777.0K$-1.3M$-1.5M$3.0M--------$30.9M
Depreciation & Amortization
--$218.4K$156.0K$-338.0K$1.1M$3.0M$8.2M$9.7M$3.5M$2.7M
Depreciation & Amortization
--$218.4K$156.0K$-338.0K$1.1M$3.0M$8.2M$9.7M$3.5M$2.7M
Amortization
--$218.4K$156.0K--$1.1M$3.0M$8.2M$9.7M$3.5M$2.7M
Other Operating Expenses
--$-374.4K----$612.0K$-60.0K$-159.0K----$-201.0K
OPERATING INCOME
Operating income
$-5.0M$-5.1M$-12.2M$-16.1M$-220.0K$-5.6M$-35.2M$-145.5M$-23.4M$-7.1M
EBITDA
$-4.7M$-7.5M$-2.0M$3.5M$-1.4M$1.1M$-17.8M$-128.3M$-13.3M$-2.8M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$100.0K$190.0K$5.0K$5.0K----------
Intinc
----$-109.0K$281.0K$501.0K$58.0K$-485.0K$-687.0K$-1.4M$-719.0K
Net Non-Operating Interest Income/Expense
--$-100.0K$-299.0K$276.0K$501.0K$58.0K$-485.0K$-687.0K$-1.4M$-719.0K
Gain on Sale of Securities
$451$-2.8M------$1.3M--$697.0K--$-4.1M
Other Income/Expense
$-21.8K$2.9M$-10.0M$9.2M$3.5M$-3.3M$-3.7M$-104.2M$-3.5M$3.6M
Other Special Charges
$21.8K$2.4K$11.0M$-8.5M$-12.8M$3.6M$168.0K$704.0K$1.3M$497.0K
SPECIAL ITEMS
Restructring And Mn A Income
--$-100.0K--$3.4M$3.2M----------
Special Income Charges
--$100.0K--$-3.4M$-3.2M----$-110.4M$-15.5M--
Impairment of Capital Assets
--------------$110.4M$15.5M--
PRE-TAX INCOME
EBIT
$-5.0M$-7.9M$-2.4M$3.3M$-3.2M$-4.0M$-30.6M$-144.8M$-25.6M$-11.4M
Pre-Tax Income
$-5.0M$-8.0M$-2.5M$-25.0M$-3.2M$-597.0K$-29.0M$-144.8M$-18.5M$-11.4M
INCOME TAX
Tax Provision
$-265.7K$-900.9M$-5.4M--$-1.5M$-3.3M$-20.1M$-5.0M$-24.0K$-38.0K
NET INCOME
Net Income
$-4.2M$-6.9M$-2.5M$-25.0M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M
Net Income (Continuing Operations)
$-4.2M$-6.9M$-2.5M$-25.0M$-1.7M$2.7M$-8.9M$-139.8M$-18.4M$-11.4M
Net Income (Discontinued Operations)
$-4.2M$-6.9M$-2.5M$-25.0M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M
Net Income (Common Stockholders)
$-4.2M$-6.9M$-2.7M$-25.3M$-1.7M$2.0M$-8.9M$-139.8M$-68.0M$-20.2M
TOTALS
Total Expenses
$-11.5M$-13.1M$-12.1M$3.6M$27.1M$49.5M$139.0M$201.7M$71.6M$60.8M
SHARE & EPS DATA
Average Shares Outstanding
$12.2M$12.6M$13.3M$16.3M$19.5M$27.3M$38.5M$42.5M$43.7M$46.1M
Average Shares Outstanding (Diluted)
$12.0M$12.7M$13.3M$16.0M$19.5M$27.3M$38.5M$42.5M$43.7M$46.1M
Shares Outstanding
$12.4M$13.0M$14.1M$18.7M$24.0M$33.4M$42.1M$43.2M$45.3M$47.0M
Basic EPS
----$-0.21$-1.56$-0.09$0.09$-0.20$-3.29$-1.52$-0.88
Basic EPS (Continuing Operations)
--------$-0.09$0.09$-0.20$-3.29$-1.52$-0.69
Diluted EPS
$-0.35$-0.54$-0.21$-1.56$-0.09$-0.03$-0.20$-3.29$-1.52$-0.88
Diluted EPS (Continuing Operations)
----------$-0.03$-0.20$-3.29$-1.52$-0.69
OTHER METRICS
Accrued Preferred Stock Dividends
----$213.0K$339.0K$1.7M$954.0K$8.9M$139.8M$66.4M--
Acquisition Expense
--------$940.0K$668.0K$1.6M$18.0K----
Basic Discontinuous Operations
------------------$-0.19
Diluted Discontinuous Operations
------------------$-0.19
Earnings from equity interest
----$-1.0M$-672.0K$-739.0K----------
Earnings From Equity Interest Net Of Tax
----$-1.0M$-672.0K$-739.0K----------
Gain On Sale Of P P E
--$-1.2K----------------
Gains Loss On Disposal Of Discontinued Operations
----------------$-193.0K$-132.0K
Interest Expense Operating
----$-38.0K$-5.0K------------
Minority Interests
$781.4K$1.2M----------------
Net Income Discontinuous Operations
----------------$-49.6M$-8.8M
Other Gain Loss From Disposition Of Discontinued Operations
----------------$-49.4M$-8.7M
Other Gand A
$4.9M$4.6M$4.5M$6.0M$8.9M$14.6M$33.7M$47.7M$43.3M$40.5M
Other Write Down
--$86.7K$108.7K--------------
Otherunder Preferred Stock Dividend
----$213.0K$339.0K$1.7M$954.0K$8.9M$139.8M$66.4M--
Preferred Stock Dividends
----$213.0K$339.0K$1.7M$954.0K$8.9M$139.8M$66.4M--
Rent And Landing Fees
$4.9M$4.6M$4.5M$6.0M------------
Selling Expense
$2.6M$3.0M$2.1M$2.6M------------
Restruct
--$-100.0K--$3.4M$3.2M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BLFS$25.05+0.5%354.49K
3
4
5
6

Get BioLife Solutions Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.